The World Health Organisation (WHO) has revealed that Nigeria will be part of the global solidarity drug trial to combat coronavirus (COVID-19).
Naija News reports that the world health body launched solidarity drug trials for these specific drugs – hydroxychloroquine, chloroquine phosphate, and remdesivir – in April.
Speaking to newsmen on Friday during the presidential task force (PTF) on COVID-19 media briefing, Fiona Braka, the officer in charge, WHO Nigeria, said drug trials would woon begin in the country.
According to Braka, more than 100 countries have joined the solidarity clinical trial, which was launched by WHO and some partners, to help find an effective treatment for COVID-19.
She said: “Nigeria has also expressed interest to be part of this solidarity trial and efforts are underway to start the process in Nigeria too.
“Together with global health actors and partners, over the past week, WHO launched the access to COVID-19 tools ACT accelerator, a global collaboration to accelerate development for equitable access to new COVID-19 diagnostics, therapeutics and vaccines.
“We have a total of 89 vaccines that are in development globally, including seven in clinical evaluation and several therapeutics are in clinical trials. WHO is committed to ensuring that as medicines and vaccines are developed, they are shared equitably with all countries and people.
“We do have the solidarity trial which is an international clinical trial to help find an effective treatment for COVID-19, launched by the WHO and partners. More than 100 countries have joined the solidarity trial and to date, over 1,200 patients have been randomized from the first five countries to evaluate the safety and efficacy of full drug and drug combinations.”
According to the NCDC 92 cases of COVID-19 was also reported in Kano State despite the 80 cases it recorded the previous day.
The latest update means there are now 2170 confirmed cases of COVID-19 in Nigeria. Discharged: 351, Deaths: 68.